Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2013-002395-40Phase 3Completed
Phase 3, open-label, single-arm trial of metformin in congenital adrenal hyperplasia (CAH), sponsored by Ghent University Hospital. Primary endpoints: Body composition, Lipid profile and 4 more. Started Nov 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2013-002395-40.